ESCRS - Extracting the Right Solution ;
ESCRS - Extracting the Right Solution ;
Cataract

Extracting the Right Solution

Both simultaneous and sequential cataract extraction improve visual outcomes; simultaneous may be better for older patients.

Extracting the Right Solution
Howard Larkin
Howard Larkin
Published: Friday, September 30, 2022

For patients undergoing both cataract extraction and pars plana vitrectomy (PPV) surgery, visual acuity and refractive improvements were similar—whether conducted as a simultaneous, combined procedure or as separate, sequential procedures, according to a study reported by Abdelhalim A Awidi MD.

Since cataract progression typically hastens after PPV and advances quicker in older patients, a simultaneous approach may be suitable for patients more than 60 years of age, Dr Awidi added. This approach can minimise the added risks of intraoperative and postoperative complications associated with increased trips to the operating room.

He outlined three scenarios that require both cataract extraction and PPV. The first is a patient presenting initially with a dense cataract, which, after extraction, subsequently reveals a posterior segment pathology such as epiretinal membrane. This scenario typically results in a sequential cataract extraction and PPV procedure approach. The second is a patient with a known posterior pathology who undergoes PPV surgery and develops a cataract requiring extraction afterwards, as cataracts are one of the most common complications following PPV. The third is a patient presenting with coexisting cataract and retinal pathology. Regardless of procedure timing, improvements in visual acuity and refractive outcomes are significant compared to preoperative measures after two operations, Dr Awidi said.

IMPROVED VISION

In a retrospective study involving 427 eyes in 404 patients over a two-year period, Dr Awidi and colleagues at the Wilmer Eye Institute assessed uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), and spherical equivalent and refractive target before surgery. They observed the patients 1, 3, 6, 12, and 24 months after surgery. The three treatment groups were PPV followed by cataract extraction, PPV and cataract extraction combined, and cataract extraction followed by PPV. Only patients who had an epiretinal membrane or vitreous opacities diagnosis—undergoing either combined PPV and cataract extraction or PPV sequentially before cataract extraction—were included in spherical equivalent and refractive prediction error analyses.

The team saw improvement in UCVA and BCVA of the whole patient cohort at every follow-up visit compared with preoperative measures, Dr Awidi reported. There were statistically significant differences in absolute BCVA among the three treatment groups at 1 and 12 months after combined or the second surgery.

However, there were no significant differences in spherical equivalent or predicted postoperative refractive error between the PPV followed by cataract extraction and the combined surgery groups at 1 and 3 months, or 6 and 24 months, after surgery.

The study also examined the timing of sequential surgeries, as a history of either surgery was an inclusion criteria for the project. Almost two-thirds of patients who underwent PPV first had cataract extraction within one year, and 94% within two years. These figures reflect the rapid progression of cataracts after PPV. Nearly 60% of patients who had cataract extraction first had PPV within one year, and 81% within two years.

“A simultaneous approach could be a suitable option for patients [older than] the age of 60 in elective or emergency situations, as it avoids the hastened deterioration in vision seen with advanced age that arises with the progression of cataracts following PPV,” he said.

Dr Awidi presented at the American Society of Cataract and Refractive Surgery 2022 Annual Meeting in Washington, DC, US.

Abdelhalim A Awidi MD is a post-doctoral research fellow at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, US. aawidi1@jhmi.edu

Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;